Abatacept versus hydroxychloroquine for prevention of rheumatoid arthritis in individuals with palindromic rheumatism: a randomized open-label trial
20d ago1 min readNews
From the article
Can abatacept beat hydroxychloroquine in preventing rheumatoid arthritis for palindromic patients? 70 individuals tested with promising outcomes. Stay tuned! PMID:42135532, Nat Med 2026, @NatureMedicine #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪
Continue reading on doi.orgYou might also wanna read
Four JAK Inhibitors Show Positive Late-Stage Trial Results for Axial Spondyloarthritis Treatment
Positive results from late-stage clinical trials of four JAK inhibitors (filgotinib, gecacitinib, ivarmacitinib, and tofacitinib) for treati
mdsc.pe·17d agoA Phase IIa Study of JAB-8263 in Patients With Active Rheumatoid Arthritis
clinicaltrials.gov·3d ago
A Study to Evaluate Luspatercept Utilization in Patients With Lower Risk Myelodysplastic Syndromes or Beta-thalassemia
clinicaltrials.gov·7d ago
Roll-Over Study of Alpelisib (BYL719) for Continued Access and Long-Term Safety.
clinicaltrials.gov·8d ago
The Safety and Efficacy of Upadacitinib in Refractory Autoimmune Related Cholangitis and Atopic Dermatitis With Moderate to Severe Itching
clinicaltrials.gov·8d ago
A Study of Trastuzumab Rezetecan in Combination With Adebrelimab Versus Investigator's Choice of Therapy in Subjects With Residual Triple Negative Breast Cancer
clinicaltrials.gov·8d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.